Dare Bioscience, Inc. — Investor Relations & Filings
Filings indexed
729
across all filing types
Latest filing
2026-05-18
Regulatory Filings
Country
US
United States of America
Listing
US
DARE
Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative products for women's health. The company conducts end-to-end clinical development of therapies designed to address unmet needs in areas such as contraception, sexual health, vaginal health, and menopause. Its pipeline includes candidates like Ovaprene®, a hormone-free monthly contraceptive, and a topical sildenafil cream for female sexual arousal disorder. Dare Bioscience emphasizes a rigorous, science-based approach to develop medically credible and evidence-based solutions, aiming to close critical gaps in female healthcare.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | |
| DEF 14A - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | |
| 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-22 | English |
Browse filings by year
19 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46460962 | 8-K | 2026-05-18 | English | ||
| 46228586 | 10-Q | 2026-05-14 | English | ||
| 46297374 | 8-K | 2026-05-14 | English | ||
| 38171736 | ARS - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | ||
| 38155812 | DEF 14A - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | ||
| 35255512 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-22 | English | ||
| 34662069 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-17 | English | ||
| 34440986 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-13 | English | ||
| 33052005 | 10-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-03-26 | English | ||
| 33051992 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-03-26 | English | ||
| 32967570 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-03-17 | English | ||
| 32891310 | 8-K - DARE BIOSCIENCE, INC. (0001401914) (Filer) | 2026-03-02 | English | ||
| 32891305 | 4 - DARE BIOSCIENCE, INC. (0001401914) (Filer) | 2026-02-20 | English | ||
| 29417093 | 4 Filing | 2026-02-02 | English | ||
| 29417091 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Immuno-Biological Laboratories Co., Ltd.
Develops and supplies immunological research reagents and i…
|
4570 | JP | Manufacturing |
|
Immunocore Holdings plc
Develops TCR bispecific immunotherapies for cancer, infecti…
|
IMCR | GB | Manufacturing |
|
Immunome Inc.
Clinical-stage oncology company developing Antibody-Drug Co…
|
IMNM | US | Manufacturing |
|
Immunotech Biopharm Ltd
Researching, developing, and commercializing T cell immunot…
|
6978 | HK | Manufacturing |
|
Immunotec Inc.
Pioneer in the glutathione space, specializing in research-…
|
IMM | CA | Manufacturing |
|
Immuron Ltd
Biopharmaceutical firm developing oral polyclonal antibodie…
|
IMRN | AU | Manufacturing |
|
Imunon, Inc.
A clinical-stage biotech developing immunotherapies and DNA…
|
IMNN | US | Manufacturing |
|
IN8BIO, INC.
Clinical-stage biopharma developing gamma-delta T cell ther…
|
INAB | US | Manufacturing |
|
Incanthera plc
A therapeutics company developing targeted solutions for de…
|
INC | GB | Manufacturing |
|
INCYTE CORP
A biopharmaceutical company developing proprietary therapeu…
|
INCY | US | Manufacturing |
Dare Bioscience, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34825/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34825 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34825 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34825 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34825}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dare Bioscience, Inc. (id: 34825)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.